April 2016 Briefing - Pharmacy
Doctors Lounge,
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2016.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2016.
(HealthDay)—For patients with post-myocardial infarction (MI) heart failure, mineralocorticoid receptor antagonists (MRAs) do…
Share this article: MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure (HealthDay…
(HealthDay News) -- For patients with post-myocardial infarction (MI) heart failure, mineralocorticoid receptor antagonists (MRAs…